Table 2 Participant groups.
Participant Characteristic | Treatment | Number of Participants | |
|---|---|---|---|
Group 1 | Metabolic syndrome | Placebo | 30 |
Group 2 | Metabolic syndrome | ProAlgaZyme | 30 |
Participant Characteristic | Treatment | Number of Participants | |
|---|---|---|---|
Group 1 | Metabolic syndrome | Placebo | 30 |
Group 2 | Metabolic syndrome | ProAlgaZyme | 30 |
Lipids in Health and Disease